Regulation of Skeletal Muscle Mitochondrial Quality Control Parameters and Systemic Metabolism
骨骼肌线粒体质量控制参数和全身代谢的调节
基本信息
- 批准号:9905516
- 负责人:
- 金额:$ 29.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-05-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdultAffectAttenuatedBiogenesisBiologicalBiological AssayCellsClinicalDataDevelopmentDietEtiologyExerciseFamilyFamily memberGene ExpressionGenetic ModelsGoalsHeterozygoteHigh Fat DietHumanImpairmentInterventionMediatingMetabolicMetabolic DiseasesMetabolic dysfunctionMetabolismMitochondriaMitochondrial DiseasesMolecularMusMuscleMuscle MitochondriaMuscle functionNon-Insulin-Dependent Diabetes MellitusObesityOutcomePGC-1 proteinPPAR gammaPathologicPathway interactionsPatientsPerformancePharmacologic SubstancePhysiologicalPlayProtein IsoformsPublishingQuality ControlRegulationResearchRodentRoleSkeletal MuscleTestingTherapeuticTranscription Coactivatorbaseclinically significantexercise trainingfatty acid oxidationglucose uptakeimprovedinnovationinsightknock-downloss of functionmembermitochondrial dysfunctionnew therapeutic targetnoveloverexpressionpreservationpreventresponsesedentarytherapeutic target
项目摘要
PROJECT SUMMARY
Obesity and type II diabetes (T2D) is associated with skeletal muscle mitochondrial dysfunction. Current
pharmaceutical interventions have been limited in their ability to restore normal mitochondrial function, in part
due to limited therapeutic targets. To date, exercise is the best-known treatment for many of these metabolic
diseases. The positive effects of exercise are largely considered to be the result of both the quality control and
functionality of mitochondria. However, the molecular pathways regulating mitochondria quality control is not
fully understood. Members of the peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1)
family of transcriptional coactivators have been identified as being important to mitochondria and ultimately
muscle function. The PGC-1α isoform has been credited with being the family member responsible for most, if
not all, of beneficial changes in response to exercise. However, we observed that deletion of PGC-1α in
skeletal muscle does not affect the adaptive changes in mitochondrial parameters. Moreover, we have also
shown that simultaneously deleting both PGC-1α and PGC-1β in skeletal muscle have profound effect on
mitochondrial function, but not mitochondrial content suggesting differences in mitochondrial quality control
parameters. These data suggest that other players are involved in the regulation of mitochondrial function and
number in skeletal muscle. We are confident that the much-understudied family member PGC-1 related
coactivator (PRC) is this factor. In addition, the role PRC plays in skeletal muscle is unknown. Furthermore, the
observation that PRC is induced in response to exercise and that whole body heterozygote for PRC deletion
have a metabolic dysfunction, suggests strongly it plays a role in the exercise response. Therefore, the overall
objective of this proposal is to understand the role PRC plays in skeletal muscle with regards to mitochondrial
quality control and whole-body systemic metabolism. Using genetic models, diet induced and exercise
paradigms, cell-based and mitochondrial assays we will attempt to address this very important question.
Results from this proposal have broad implications for our understanding of metabolic disorders in skeletal
muscle as well as the role of PRC in skeletal muscle. The specific aims are to: 1.) to define the role of PRC in
skeletal muscle mitochondrial quality control, both during baseline and exercise training; 2.) to interrogate the
effect of diet-induced metabolic imbalance on mitochondrial quality control in adult skeletal muscle with
acquired mitochondrial oxidative capacity deficiency; and 3.) to demonstrate that exercise training preserves
mitochondrial quality control in adult skeletal muscle with impaired oxidative capacity. This proposal will to
provide much needed insights into our understanding of PRC in skeletal muscle and its contribution to
metabolic dysfunction.
项目摘要
肥胖和II型糖尿病(T2 D)与骨骼肌线粒体功能障碍有关。电流
药物干预在恢复正常线粒体功能的能力方面受到限制,
由于治疗靶点有限。到目前为止,运动是最有名的治疗许多这些代谢性疾病的方法。
疾病锻炼的积极效果在很大程度上被认为是质量控制和
线粒体的功能。然而,调节线粒体质量控制的分子途径不是
完全理解过氧化物酶体增殖物激活受体γ共激活因子-1(PGC-1)
转录辅激活因子家族已被鉴定为对线粒体重要,并最终
肌肉功能PGC-1α亚型被认为是负责大多数,如果
不是所有的,有益的变化,以回应运动。然而,我们观察到,PGC-1α的缺失,
骨骼肌不影响线粒体参数的适应性变化。此外,我们还
同时删除骨骼肌中的PGC-1α和PGC-1β对
线粒体功能,而不是线粒体含量,表明线粒体质量控制的差异
参数这些数据表明,其他参与者参与了线粒体功能的调节,
骨骼肌中的数量。我们相信,研究不足的家庭成员PGC-1相关
辅活化剂(PRC)是该因子。此外,PRC在骨骼肌中的作用尚不清楚。而且
观察到PRC是由运动引起的,并观察到PRC缺失的全身杂合子
有代谢功能障碍,强烈表明它在运动反应中起作用。因此整体
本提案的目的是了解PRC在骨骼肌中与线粒体有关的作用,
质量控制和全身系统代谢。使用遗传模型,饮食诱导和运动
范例,基于细胞和线粒体的测定,我们将试图解决这个非常重要的问题。
这一提议的结果对我们理解骨骼肌中的代谢紊乱具有广泛的意义。
肌肉以及PRC在骨骼肌中的作用。具体目标是:(1)界定中华人民共和国在
在基线和运动训练期间的骨骼肌线粒体质量控制; 2.)询问
饮食诱导代谢失衡对成年人骨骼肌线粒体质量控制影响
获得性线粒体氧化能力缺陷;和3.)来证明运动训练可以
氧化能力受损的成年骨骼肌线粒体质量控制。这项建议将
为我们了解骨骼肌中的PRC及其对
代谢功能障碍
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Glenn Cameron Rowe其他文献
Glenn Cameron Rowe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Glenn Cameron Rowe', 18)}}的其他基金
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10615236 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10296083 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Autocrine Action of Elevated FGF-21 Contributing to Skeletal Muscle Atrophy in Response to Mitochondrial Dysfunction
FGF-21 升高的自分泌作用导致线粒体功能障碍引起的骨骼肌萎缩
- 批准号:
10469480 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌 PGC-1 共激活剂对线粒体的调节
- 批准号:
9014362 - 财政年份:2015
- 资助金额:
$ 29.7万 - 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌 PGC-1 共激活剂对线粒体的调节
- 批准号:
9124710 - 财政年份:2015
- 资助金额:
$ 29.7万 - 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌 PGC-1 共激活剂对线粒体的调节
- 批准号:
8374349 - 财政年份:2012
- 资助金额:
$ 29.7万 - 项目类别:
Regulation of Mitochondria by Exercise and PGC-1 Coactivators in Skeletal Muscle
运动和骨骼肌中 PGC-1 共激活剂对线粒体的调节
- 批准号:
8544780 - 财政年份:2012
- 资助金额:
$ 29.7万 - 项目类别:
相似海外基金
Structural Racism, Pharmacy Closures and Disparities in Medication Adherence Among Older Adult Medicare Part-D Beneficiaries
结构性种族主义、药房关闭以及老年人医疗保险 D 部分受益人的药物依从性差异
- 批准号:
10568717 - 财政年份:2023
- 资助金额:
$ 29.7万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10592441 - 财政年份:2022
- 资助金额:
$ 29.7万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10369750 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10633248 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Leveraging Technology to Improve Medication Adherence in Adolescent and Young Adult Kidney or Liver Transplant Recipients
利用技术提高青少年和年轻肾移植或肝移植受者的药物依从性
- 批准号:
10487516 - 财政年份:2021
- 资助金额:
$ 29.7万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
10228564 - 财政年份:2018
- 资助金额:
$ 29.7万 - 项目类别:
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Mhealth 促进年轻 MSM 遵守暴露前预防
- 批准号:
9347041 - 财政年份:2017
- 资助金额:
$ 29.7万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9480702 - 财政年份:2016
- 资助金额:
$ 29.7万 - 项目类别:
Mindfulness training with HIV-positive youth and adult family members to improve treatment adherence
对艾滋病毒呈阳性的青少年和成年家庭成员进行正念训练,以提高治疗依从性
- 批准号:
9906853 - 财政年份:2016
- 资助金额:
$ 29.7万 - 项目类别: